GlassScriptPhysician profile
John R Carter
NPI 1255360798
$5,252.33
in general payments reported to CMS, 2019-2025
39 companies · $661 in 2025
The $661 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $901 · 2020: $432 · 2021: $811 · 2022: $1,078 · 2023: $791 · 2024: $578 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,030.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $995.93 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Daiichi Sankyo INC. | $634.42 | 2019-2024 | Injectafer |
| Astellas Pharma US INC | $418.42 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $338.29 | 2023-2025 | Myfembree, Gemtesa |
| Duchesnay USA Incorporated | $320.44 | 2019 | |
| Evofem Biosciences, INC. | $263.05 | 2020-2024 | Phexxi |
| Pfizer INC. | $238.82 | 2019-2025 | |
| Exeltis, USA INC. | $180.65 | 2021-2025 | Slynd |
| Avion Pharmaceuticals | $156.19 | 2019-2022 | |
| Lupin INC. | $147.26 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $135.03 | 2022-2025 | |
| Davol INC. | $119.91 | 2022-2024 | Arista Ah Flexitip |
| Sage Therapeutics, LLC | $108.01 | 2022-2025 | Zurzuvae |
| Ethicon US, LLC | $95.54 | 2019-2022 | |
| Myovant Sciences INC. | $94.34 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $88.04 | 2021-2022 | |
| Organon LLC | $84.77 | 2021-2025 | Nexplanon |
| Amgen INC. | $71.75 | 2021-2025 | Evenity, Prolia |
| Amag Pharmaceuticals, INC. | $68.16 | 2019 | |
| Aspira Women'S Health INC | $67.91 | 2021 | |
| Dexcom, INC. | $64.67 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $60.74 | 2023 | Wegovy |
| Hologic Sales and Service, LLC | $50.82 | 2024-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Therapeuticsmd, INC. | $44.64 | 2019-2022 | |
| Medtronic, INC. | $41.89 | 2025 | Stealthstation S8 Platform, Ligasure |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.68 | 2020-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $39.42 | 2019-2020 | |
| Shield Therapeutics INC | $38.61 | 2024-2025 | |
| Lilly USA, LLC | $32.24 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $31.14 | 2019-2021 | |
| Avanos Medical | $28.14 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.43 | 2024-2025 | |
| Supernus Pharmaceuticals, INC. | $24.01 | 2025 | Qelbree |
| Scynexis, INC. | $21.41 | 2022 | |
| Celgene Corporation | $18.26 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.75 | 2025 | Exparel |
| Agile Therapeutics, INC. | $17.70 | 2023 | Twirla |
| Medicem INC. | $13.66 | 2020 | |
| Acell, INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.